Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.
about
Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationSurvival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trial.Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.Treatment of pathologic fracture following postoperative radiation therapy: clinical studyRandomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.A Randomized Prospective Study of Concurrent Chemo-Radiotherapy vs Accelerated Hyperfractionation in Advanced Cancer of Head and Neck.Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram.Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaRadiotherapy alone or combined with chemotherapy for base of tongue squamous cell carcinoma.Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases.Radiotherapy for laryngeal cancer—technical aspects and alternate fractionation.Biological dose-escalated definitive radiation therapy in head and neck cancer.Efficacy and toxicity profiles of two chemoradiotherapies for stage II laryngeal cancer - a comparison between late course accelerated hyperfractionation (LCAHF) and conventional fractionation (CF).Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.Treatment of late sequelae after radiotherapy for head and neck cancer.Aspiration as a late complication after accelerated versus conventional radiotherapy in patients with head and neck cancer.Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.Considerations in surgical versus non-surgical management of HPV positive oropharyngeal cancer.Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis
P2860
Q26744490-16070993-BBCA-42E4-8E0D-2D1D9D4FA395Q31057366-D7F67235-A06B-4EFA-9EB1-C05F78CA522FQ33809126-A89E6B4F-A702-4D11-A197-11507D14419BQ35676762-5C5C86EF-D060-4FFA-BC57-30B96F8D7ADAQ36074100-EA0DAE1B-2A4A-4F40-ACBA-AFED7AFA4F8CQ36391761-12282E5A-B633-422C-84E9-B2F3AEF8B281Q36451821-137FFC0A-0679-434A-9E2C-EB72AC0A9C9EQ36603161-B44F245B-ACA4-45DE-B190-ED4CB1E3CA3DQ37435817-0B51278E-214F-49C0-A717-E8DE8F379163Q37676732-49C47F3F-311A-4A6D-B5F0-808D7C7A94B8Q37690150-910F152B-4A25-4413-B62A-5D5CAB30FA53Q38252802-FD91A098-791D-47BD-9CA9-B2ED55B240B4Q38257116-4397DB8A-4848-43F0-AAEC-A0241B75BB1BQ38400679-C94E7595-FF2A-4BBB-93E2-102AB9280433Q38602875-D5324AE2-DAFF-455D-8511-970DBDD5D933Q38850017-C1D114C3-A762-4B2A-B165-F6EF652EC5B2Q38864755-4AF7ECC0-3B90-4D50-B017-5116D6B1A6F9Q38924379-1DEE01C8-F4BC-4705-9FF0-E1809B561DCEQ38944348-2DD8DFFC-A957-4369-B43A-56CE0C1062FAQ38952268-889E9A32-8C48-4501-A07E-BFE5687A5BB1Q39669627-46D5F889-7EE1-4CBB-8094-924D8685A6ACQ40542708-97B6C4DD-B222-4662-9E47-5DE6159E61D7Q41711103-C2FAA3E6-589C-4E44-9968-C3A3E19F18C1Q42376426-0E1F1411-DCE2-4313-AE85-2C9D4C2B8C07Q46322072-40D24652-8F17-46B5-BDD7-575F99732C0AQ47976649-704ED341-E5C6-43A4-B77B-D65DBCD3FEE2Q48115920-49AC8FF0-EB29-4D92-B99E-F4D3C750E42AQ48663507-AE40B006-5FEF-4069-B609-B3609E889CAEQ50307416-C3E8E792-9526-4FB9-89DF-03CDF6F27156Q51550250-AF996705-8BA0-4644-9ACB-9021319D5B16Q53090717-3BF3B275-059E-481F-A241-65558DE99729Q53789934-29C1BEB0-CD09-4755-B655-EF069E442407Q55035025-2DACB552-D302-4D42-9F22-FC1F34ED8BE2Q56532845-49DBCC0B-A897-416E-B7A4-544EF5FE3345Q58764983-781771DB-B2F6-4C8E-BC84-D7F8725B0AC0
P2860
Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Final results of local-regiona ...... advanced head and neck cancer.
@ast
Final results of local-regiona ...... advanced head and neck cancer.
@en
type
label
Final results of local-regiona ...... advanced head and neck cancer.
@ast
Final results of local-regiona ...... advanced head and neck cancer.
@en
prefLabel
Final results of local-regiona ...... advanced head and neck cancer.
@ast
Final results of local-regiona ...... advanced head and neck cancer.
@en
P2093
P2860
P1476
Final results of local-regiona ...... advanced head and neck cancer.
@en
P2093
Adam S Garden
Andy Trotti
Christopher U Jones
George Shenouda
Jonathan Harris
Jonathan J Beitler
Karen K Fu
Kian K Ang
Qiang Zhang
Sharon A Spencer
P2860
P356
10.1016/J.IJROBP.2013.12.027
P407
P577
2014-03-07T00:00:00Z